4.5 Article

Sitagliptin attenuates methionine/choline-deficient diet-induced steatohepatitis

期刊

DIABETES RESEARCH AND CLINICAL PRACTICE
卷 105, 期 1, 页码 47-57

出版社

ELSEVIER IRELAND LTD
DOI: 10.1016/j.diabres.2014.04.028

关键词

Non-alcoholic steatohepatitis (NASH); Sitagliptin; MCD diet; GLP-1; DPP-4 inhibitor

资金

  1. National Research Foundation of Korea - Ministry of Science, ICT & Future Planning [2011-0028659, 2012R1A2A2A01043867, 2012R1A1A1010047]
  2. Korea Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [A111345]
  3. National Research Foundation of Korea [2012R1A2A2A01043867, 2012R1A1A1010047, 2011-0028659] Funding Source: Korea Institute of Science & Technology Information (KISTI), National Science & Technology Information Service (NTIS)

向作者/读者索取更多资源

Aims: Accumulating evidence suggests that inhibitors of dipeptidyl peptidase-4 (DPP-4), such as sitagliptin, may play an important role in the prevention of non-alcoholic steatohepatitis (NASH). This study was conducted to elucidate whether sitagliptin could prevent steatohepatitis by inhibiting pathways involved in hepatic steatosis, inflammation, and fibrosis. Methods: C57BL/6 mice were fed a methionine/choline-deficient (MCD) diet with or without supplement with sitagliptin for 5 weeks. Liver and adipose tissue from mice were examined histologically and immunohistochemically to estimate the effect of sitagliptin on the development of NASH. Results: Supplementation with sitagliptin resulted in significant improvement of MCD diet-induced fat accumulation in the liver. In addition, sitagliptin treatment lowered fatty acid uptake, expression of VLDL receptor and hepatic triglyceride content. Sitagliptin also effectively attenuated MCD diet-induced hepatic inflammation, endoplasmic reticulum (ER) stress, and liver injury, as evidenced by reduced proinflammatory cytokine levels, ER stress markers, and TUNEL staining. Expression of CYP2E1 and 4NHE were strongly increased by the MCD diet, but this effect was successfully prevented by sitagliptin treatment. Furthermore, sitagliptin significantly decreased levels of MCD diet-induced fibrosis-associated proteins such as fibronectin and alpha-SMA in the liver. Inflammatory and atrophic changes of adipose tissue by MCD diet were restored by sitagliptin treatment. Conclusions: Sitagliptin attenuated MCD diet-induced hepatic steatosis, inflammation, and fibrosis in mice through amelioration of mechanisms responsible for the development of NASH, including CD36 expression, NF-kappa B activation, ER stress, CYP2E1 expression, and lipid peroxidation. Treatment with sitagliptin may represent an effective approach for the prevention and treatment of NASH. (C) 2014 Elsevier Ireland Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Cell Biology

Src Inhibition Attenuates Liver Fibrosis by Preventing Hepatic Stellate Cell Activation and Decreasing Connective Tissue Growth Factor

Hye-Young Seo, So-Hee Lee, Ji-Ha Lee, Yu Na Kang, Jae Seok Hwang, Keun-Gyu Park, Mi Kyung Kim, Byoung Kuk Jang

Article Nutrition & Dietetics

Effects of Branched-Chain Amino Acid (BCAA) Supplementation on the Progression of Advanced Liver Disease: A Korean Nationwide, Multicenter, Prospective, Observational, Cohort Study

Jung Gil Park, Won Young Tak, Soo Young Park, Young Oh Kweon, Woo Jin Chung, Byoung Kuk Jang, Si Hyun Bae, Heon Ju Lee, Jae Young Jang, Ki Tae Suk, Myung Jin Oh, Jeong Heo, Hyun Young Woo, Se Young Jang, Yu Rim Lee, June Sung Lee, Do Young Kim, Seok Hyun Kim, Jeong Ill Suh, In Hee Kim, Min Kyu Kang, Won Kee Lee

NUTRIENTS (2020)

Article Gastroenterology & Hepatology

Independent Risk Factors for Hepatocellular Carcinoma Recurrence after Direct-Acting Antiviral Therapy in Patients with Chronic Hepatitis C

Young-Hwan Ahn, Heirim Lee, Do Young Kim, Hye Won Lee, Su Jong Yu, Young Youn Cho, Jeong Won Jang, Byoung Kuk Jang, Chang Wook Kim, Hee Yeon Kim, Hana Park, Hyo Jung Cho, Bumhee Park, Soon Sun Kim, Jae Youn Cheong

Summary: This study evaluated the efficacy of DAA therapy in Korean patients with HCV-related HCC and found a correlation between short last HCC treatment duration and HCC recurrence. The results suggest that the last HCC treatment duration is an important predictor of HCC recurrence after DAA therapy.

GUT AND LIVER (2021)

Article Multidisciplinary Sciences

Kahweol activates the Nrf2/HO-1 pathway by decreasing Keap1 expression independently of p62 and autophagy pathways

Hye-Young Seo, So-Hee Lee, Ji-Ha Lee, Jae Seok Hwang, Mi Kyung Kim, Byoung Kuk Jang

PLOS ONE (2020)

Article Biochemistry & Molecular Biology

Kahweol Induces Apoptosis in Hepatocellular Carcinoma Cells by Inhibiting the Src/mTOR/STAT3 Signaling Pathway

Hye-Young Seo, So-Hee Lee, Ji-Ha Lee, Jae-Ho Lee, Byoung Kuk Jang, Mi Kyung Kim

Summary: The study found that kahweol induces apoptosis in hepatocellular carcinoma cells by inhibiting the phosphorylation of specific signaling pathways, suggesting it as a potential inhibitor of HCC cell growth.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Gastroenterology & Hepatology

High Sodium Intake, as Assessed by Urinary Sodium Excretion, Is Associated with Nonalcoholic Fatty Liver Disease or Sarcopenia

Eugene Han, Mi Kyung Kim, Seung-Soon Im, Hye Soon Kim, Taeg Kyu Kwon, Byoung Kuk Jang

Summary: This study investigated the association between high sodium intake and the risk of sarcopenia and nonalcoholic fatty liver disease (NAFLD). The results showed that participants with high urinary sodium excretion had a significantly higher risk of NAFLD and sarcopenia.

GUT AND LIVER (2023)

Article Biochemistry & Molecular Biology

Evogliptin Directly Inhibits Inflammatory and Fibrotic Signaling in Isolated Liver Cells

Hye-Young Seo, So-Hee Lee, Eugene Han, Jae Seok Hwang, Sol Han, Mi Kyung Kim, Byoung Kuk Jang

Summary: In this study, we found that evogliptin can inhibit inflammatory and fibrotic signaling in liver cells and induce autophagy.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Cell Biology

Increased Levels of Phosphorylated ERK Induce CTGF Expression in Autophagy-Deficient Mouse Hepatocytes

Hye-Young Seo, So-Hee Lee, Eugene Han, Jae Seok Hwang, Mi Kyung Kim, Byoung Kuk Jang

Summary: Autophagy deficiency leads to increased expression of fibrosis-associated genes in liver cells, causing liver injury.
Article Chemistry, Analytical

The Integration of Reference Electrode for ISFET Ion Sensors Using Fluorothiophenol-Treated rGO

Dae Hoon Kim, Hae Shin Cho, Jin Heung Kim, Da Ae Jo, Hong Gi Oh, Byoung Kuk Jang, Kwang Soup Song

Summary: In this study, we successfully integrated fluorinated reduced graphene oxide (F-rGO) as a new reference electrode (RE) in microscale ion-sensitive field-effect transistors (ISFETs) sensors. The F-rGO RE showed stable operation, high sensitivity, and low hysteresis voltage, enabling fast and accurate detection of specific ions in solution.

BIOSENSORS-BASEL (2023)

Article Oncology

Efficacy of Liver-Directed Combined Radiotherapy in Locally Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis

Jina Kim, Jason Chia-Hsien Cheng, Taek-Keun Nam, Jin Hee Kim, Byoung Kuk Jang, Wen-Yen Huang, Hiroshi Aikata, Myungsoo Kim, Jung Hyun Kwon, Jinbo Yue, Victor Ho Fun Lee, Zhaochong Zeng, Jinsil Seong

Summary: This study compared the efficacy of liver-directed combined radiotherapy (LD combined RT) with sorafenib in hepatocellular carcinoma patients presenting portal vein tumor thrombosis. The LD combined RT group showed significantly improved overall survival and a higher conversion rate to curative surgery. Despite the multimodality of the treatment, LD combined RT had comparable toxicity rates to sorafenib.

CANCERS (2023)

Article Multidisciplinary Sciences

Lobeglitazone inhibits LPS-induced NLRP3 inflammasome activation and inflammation in the liver

Hye-Young Seo, So-Hee Lee, Ji Yeon Park, Eugene Han, Sol Han, Jae Seok Hwang, Mi Kyung Kim, Byoung Kuk Jang

Summary: This study demonstrates the potential of lobeglitazone in inhibiting liver inflammation and fibrosis by reducing NLRP3 inflammasome activation and production of proinflammatory cytokines.

PLOS ONE (2023)

Article Medicine, General & Internal

Diagnostic value of serum procalcitonin and C-reactive protein in discriminating between bacterial and nonbacterial colitis: a retrospective study

Jae Yong Lee, So Yeon Lee, Yoo Jin Lee, Jin Wook Lee, Jeong Seok Kim, Ju Yup Lee, Byoung Kuk Jang, Woo Jin Chung, Kwang Bum Cho, Jae Seok Hwang

Summary: This study found that serum PCT and CRP have limited value in differentiating between bacterial and nonbacterial colitis, and are not effective in discriminating between the two conditions.

JOURNAL OF YEUNGNAM MEDICAL SCIENCE (2023)

Article Medicine, General & Internal

Toxocara canis and Fasciola hepatica Co-Infection Leading to Hepatic Abscess: A Case Report

Seung Wan Kim, Byoung Kuk Jang

Summary: This article reports a case of a 39-year-old woman diagnosed with a liver abscess caused by co-infection of Toxocara canis and Fasciola hepatica. The patient may have acquired the infections through ingestion of eggs from contaminated soil and consumption of contaminated water or aquatic plants.

JOURNAL OF KOREAN MEDICAL SCIENCE (2023)

Article Medicine, General & Internal

A Multi-Center, Double-Blind Randomized Controlled Phase III Clinical Trial to Evaluate the Antiviral Activity and Safety of DA-2802 (Tenofovir Disoproxil Orotate) and Viread (Tenofovir Disoproxil Fumarate) in Chronic Hepatitis B Patients

Hyung Joon Kim, Ju Hyun Kim, Jong Eun Yeon, Yeon Seok Seo, Jeong Won Jang, Yong Kyun Cho, Byoung Kuk Jang, Byung Hoon Han, Changhyeong Lee, Joon Hyeok Lee, Jung-Hwan Yoon, Kang Mo Kim, Moon Young Kim, Do Young Kim, Neung Hwa Park, Eun Young Cho, June Sung Lee, Jin-Woo Lee, In Hee Kim, Byung-Cheol Song, Byung-Seok Lee, Oh Sang Kwon

Summary: This study demonstrates that DA-2802 is an effective and safe treatment option for patients with chronic hepatitis B. After 48 weeks of treatment, there was a significant reduction in HBV DNA levels in the DA-2802 group. There were no significant differences in the secondary efficacy endpoints between the two groups, and the frequency of adverse events was similar.

JOURNAL OF KOREAN MEDICAL SCIENCE (2022)

Article Medicine, General & Internal

Changes in Characteristics of Patients with Liver Cirrhosis Visiting a Tertiary Hospital over 15 Years: a Retrospective Multi-Center Study in Korea

Won Young Jang, Woo Jin Chung, Byoung Kuk Jang, Jae Seok Hwang, Heon Ju Lee, Moon Joo Hwang, Young Oh Kweon, Won Young Tak, Soo Young Park, Su Hyun Lee, Chang Hyeong Lee, Byung Seok Kim, Si Hye Kim, Jeong Ill Suh, Jun Gi Park

JOURNAL OF KOREAN MEDICAL SCIENCE (2020)

暂无数据